PRACS Institute is a leading early-phase contract research organization. A pioneer in the eary phase research space, PRACS Institute has conducted more than 20,000 clinical pharmacology studies, more than any other CRO. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas, including asthma and allergy, dermatology and diabetes, as well as bioanalytical services to support clinical, preclinical drug and biomarker analysis for small and large molecules.